EUS-guided FNA in the Study of the Adrenal Gland

EUS-guided FNA in the Study of the Adrenal Gland: National Retrospective Multicenter Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03327142

Enrollment

204

Registered

2017-10-31

Start date

2015-12-08

Completion date

2016-04-30

Last updated

2017-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adrenal Gland Disease, Adrenal Tumor

Keywords

Adrenal Gland, Endoscopic Ultrasound Guided FNA

Brief summary

To analyze the diagnostic performance, safety, impact on clinical management, predictors of malignancy and cyto-pathological correlation of the EUS-FNA with AG. National multicenter retrospective study. Mailing-SEED partners. Participation: 17 Spanish centers. Inclusion period: April / 2003 to April / 2016 Inclusion criteria: All AG (Left / Right) punctured by EUS. A review of 205 EUS-FNA of AG in 200 patients is included.

Detailed description

INTRODUCTION: The EUS has proven useful in the study and evaluation of the adrenal gland (AG) by endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA), in both the left and right glands. OBJECTIVE: To analyze the diagnostic performance, safety, impact on clinical management, predictors of malignancy and cyto-pathological correlation of the EUS-FNA with AG. MATERIALS AND METHODS: National multicenter retrospective study. Mailing-SEED partners. Participation: 17 Spanish centers. Inclusion period: April / 2003 to April / 2016 Inclusion criteria: All AG (Left / Right) punctured by EUS. Variables reviewed: Demographic characteristics, clinical, extension studies, USE and pathological data. Comparison between variables; and estimation of multivariate logistic model for cytology, mortality and therapeutic change.

Interventions

DIAGNOSTIC_TESTEndoscopic Ultrasound-Guided FNA

Endoscopic Ultrasound Guided Fine Needle Aspiration of Puncture of Adrenal Glands

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* All adrenal gland (Left / Right) punctured by endoscopic ultrasound

Design outcomes

Primary

Measure	Time frame
Diagnostic accuracy	retrospective analysis form 2003 to 2016

Secondary

Measure	Time frame	Description
number of adverse events related to the procedure	retrospective analysis, last 10 years	—
Predictors of malignancy	retrospective analysis, last 10 years	Predictors of malignancy and cyto-pathological correlation of the EUS-FNA with adrenal gland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026